Literature DB >> 4200651

In vitro activity of cefazolin against recent clinical bacterial isolates.

L D Sabath, C Wilcox, C Garner, M Finland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4200651     DOI： 10.1093/infdis/128.supplement_2.s320

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.

Authors:  G D Overturf; R L Ressler; P B Marengo; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents.

Authors:  M Finland; C Garner; C Wilcox; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.

Authors:  R N Jones; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

4.  In vitro activity of BL-s640 against gram-negative bacilli and Staphylococcus aureus compared with activity of four other semisynthetic cephalosporins.

Authors:  A Vuye; J Pijck; H Soep
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Pharmacology of cephalothin in the biliary tract of humans.

Authors:  J Mendelson; J Portnoy; H Sigman; V Dick
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  Treatment of cellulitis with ceforanide.

Authors:  D M Musher; V Fainstein; E J Young
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

7.  Treatment of osteomyelitis and septic arthritis with cefazolin.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.